BioTie Therapies Corp.: Selincro Launched in the United Kingdom

Published: May 06, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has launched Selincro in the United Kingdom. According to the terms of the license agreement between Biotie and Lundbeck for Selincro, Biotie is eligible for a milestone payment of EUR 2 million related to the UK launch. Biotie will potentially contribute to Lundbeck towards any required post approval commitment studies. These contributions are not expected to be significant in 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news